BioCydex has obtained CIR accreditation until 2021.
Drug Development Services
Drug Delivery Solutions
early stage data before
expensive and extensive developments
Drug Delivery Systems
BioCydex develops products and procedures designed for the formulation and delivery of active principles in the field of Human Health and Biological engineering.
Organ, Tissue & Cell preservation
BioCydex develops and commercialize its own chemical products and innovative solutions in the field of organ, tissue and cell preservation.
BioCydex develops chemical and physico-analytical methods (HPLC, NMR, IR,…) under US and European Pharmacopoeia guidelines.
The technological know-how developed by BioCydex constitutes a catalog of more than 15 modified cyclodextrins.
BioCydex has successfully completed its preclinical study on kidney transplantation under dynamic perfusion conditions after a warm ischemic phase...
BioCydex has been awarded 150 k€ in the final development of Vectisol®, which will fund collaboration with INSERM Laboratory (UMR...
Undoing the scientific locks for optimal development
BioCydex is at the cutting edge of research providing solutions and technologies which when implemented radically improve the developments of innovative routes in the field of Human Health and Biological engineering.
The know-how of BioCydex is the consequence of its intensive research since 15 years.
At BioCydex, fundamental priorities are scientific and business integrity.